On Monday shares of Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) closed at $17.32. Company’s sales growth for last 5 years was 5.80%. On April 22, Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), announced that it will hold a conference call and webcast on Wednesday, May 6, 2015 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and first quarter financial results.
Applied Genetic Technologies Corporation (NASDAQ:AGTC) in last trading activity moved down -5.57% to close at $20.53. Company weekly performance is -1.82% while its quarterly performance stands at -15.51%. Applied Genetic Technologies Corporation (NASDAQ:AGTC) is -40.27% away from its 52 week high. Applied Genetic Technologies Corporation (NASDAQ:AGTC), announced its participation in Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) — Denver, Colo. (May 3-7, 2015).
On last trading day Mettler-Toledo International Inc. (NYSE:MTD) moved down -0.63% to close at $320.02. Its volatility for the week is 1.31% while volatility for the month is 1.63%. MTD’s sales growth for past 5 years was 7.50% and its EPS growth for past 5 years was 17.90%. Mettler-Toledo International Inc. (NYSE:MTD) monthly performance is 0.36%. Mettler-Toledo International (NYSE:MTD) has received an “A” credit rating from analysts at Morningstar. The research firm’s “A” rating suggests that the company is a low default risk. They also gave their stock a one star rating.
Internap Corporation (NASDAQ:INAP) has 2.80% insider ownership while its institutional ownership stands at 82.10%. In last trading activity company’s stock closed at $10.39. RDG Capital Fund Management, a significant shareholder of Internap Corp. (NASDAQ:INAP), announced that it strongly recommended the Board of the company retain a nationally recognized investment banking advisor to explore strategic alternatives to maximize shareholder value, including a potential sale or merger.
On last trading day MannKind Corp. (NASDAQ:MNKD) moved down -4.38% to close at $4.59. Its volatility for the week is 3.68% while volatility for the month is 3.18%. MNKD’s EPS growth for past 5 years was 24.40%. MannKind Corp. (NASDAQ:MNKD) monthly performance is -10.18%. MannKind Corporation (NASDAQ:MNKD) announced that it will begin to manufacture a 12 unit cartridge strength of AFREZZA (insulin human) Inhalation Powder to improve glycemic control in adult patients with diabetes. The 12 unit cartridge was approved by the U.S. Food and Drug Administration on April 17, 2015 and is expected to be launched by Sanofi in the second half of 2015.